• Company name: Bioink Solution, Inc. (since April 25, 2018)
  • CEO: Jang Soo Suh, MD, PhD, Professor of Kyungpook National University, Korea
  • Location: 807 Hoguk-ro, Buk-gu, Daegu 41404, Korea
  • Main business model: Bioinks for 3D bioprinting & additive manufacturing and bioink-based medical devices

Scientific Advisory Board
  • Moon Suk Kim, PhD, Professor, Ajou University, Korea
  • Grace Lim, PhD, Professor, Kyungpook National University, Korea
  • Tae G. Kwon, MD, PhD, Professor, Kyungpook National University, Korea

Management Advisory BoArd
  • Young Kwon. Yoon, MD, PhD, Yonsei Heal Rehabilitation Clinic, Korea
  • Hoon Je Cho, PhD, CEO of ActnerLAB, Korea

Company Mission
  • Bioink Solution, Inc. is committed to develop and provide standardized bioinks that are optimally formulated for bioprinting of cells, tissues, and organs.
  • Our mission is to contribute to the advancement of bioprinting/biofabrication field that will change the way medicine is practiced.

  • Kyungpook National University Hospital, Korea (R&D)
  • WFIRM, Wake Forest School of Medicine, USA (R&D)
  • University of Otago, New Zealand (R&D)
  • Ajou University, Korea (R&D)
  • DGMIF, Daegu, Korea (R&D)
  • ROKIT, Korea (Distribution)
  • 3DYNAMIC SYSTEMS, UK (Distribution)
  • MedPrin, China (R&D, Distribution; Pending)

Technology and Resources
  • Intellectual property: Bio-ink composition having improved physical and biological properties (WO2017014582 A1) (PCT/KR2016/007962) and 4 more patents
  • Government-Sponsored Project: Development of skin regenerative patch for wound healing and 3 more projects (USD $700,000)